×

Cramer's Stop Trading: GW Pharma becoming 'non-speculative'

9:55 AM ET Tue, 17 June 2014

GW Pharmaceuticals is developing effective treatments based on chemical cannabinoids found in marijuana to treat seizures. CNBC's Jim Cramer looks at reports of promising results from its drug Epidiolex.